Is there a genetic factor in flecainide toxicity?
BMJ
.
1988 Nov 19;297(6659):1316.
doi: 10.1136/bmj.297.6659.1316.
Authors
J Beckmann
1
,
R Hertrampf
,
U Gundert-Remy
,
G Mikus
,
A S Gross
,
M Eichelbaum
Affiliation
1
Abteilung für Experimentelle und Klinische Pharmakologie, Bundesgesundheitsamt, Berlin, Federal Republic of Germany.
PMID:
3144374
PMCID:
PMC1834956
DOI:
10.1136/bmj.297.6659.1316
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Flecainide / adverse effects*
Flecainide / metabolism
Flecainide / pharmacokinetics
Half-Life
Humans
Metabolic Clearance Rate
Phenotype
Sparteine / metabolism
Substances
Sparteine
Flecainide